Global Autoinjectors Industry

GlobeNewswire

Autoinjectors market worldwide is projected to grow by US$89. 1 Billion, driven by a compounded growth of 22. 7%. Rheumatoid Arthritis, one of the segments analyzed and sized in this study, displays the potential to grow at over 24.

New York, May 09, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Autoinjectors Industry" - https://www.reportlinker.com/p05797940/?utm_source=GNW
4%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$41.9 Billion by the year 2025, Rheumatoid Arthritis will bring in healthy gains adding significant momentum to global growth.

- Representing the developed world, the United States will maintain a 20.8% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$3.9 Billion to the region’s size and clout in the next 5 to 6 years. Over US$3.2 Billion worth of projected demand in the region will come from Rest of Europe markets. In Japan, Rheumatoid Arthritis will reach a market size of US$1.7 Billion by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 27.1% over the next couple of years and add approximately US$20.5 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

- Competitors identified in this market include, among others,

  • AbbVie, Inc.

  • Amgen, Inc.

  • Antares Pharma, Inc.

  • Becton, Dickinson and Company

  • Consort Medical PLC

  • Eli Lilly and Company

  • Haselmeier GmbH

  • Mylan NV

  • Owen Mumford Ltd.

  • SHL Group

  • Teva Pharmaceutical Industries Ltd.

  • Ypsomed AG




Read the full report: https://www.reportlinker.com/p05797940/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Rapid Shift from Self-Injectors to Autoinjectors for Easy and
Safe Administration of Drugs Drives Demand
North America: The Largest Market for Autoinjectors
Global Competitor Market Shares
Autoinjectors Competitor Market Share Scenario Worldwide
(in %): 2019 & 2025
Global Epinephrine Autoinjector market: Percentage Breakdown of
Volume Sales by Leading Players for the Year 2019E


2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Rising Prevalence of Targeted Therapies such as Cancer,
Rheumatoid Arthritis, Multiple Sclerosis and Diabetes:
A Strong Growth Driver
Number of New Cases of Cancer Worldwide for the Years 2012,
2015, 2020, 2025 and 2030
Diabetes Prevalence in the Age-Group of 20-79 Years in Millions
by Region for the Years 2018, 2021 and 2025
Global Injectable Drug Delivery Market: Revenues in US$ Billion
for the Years 2016, 2018, 2020, 2022 and 2024
Rising Incidence of Anaphylaxis and Increased Prescription Rate
of Epinephrine Autoinjectors Boosts Market Demand
Increasing Number of Regulatory Approvals for Autoinjectors in
Various Diseases
Generic Autoinjectors Take Center Stage
Patent Expiry of Biologics to Drive the Demand for Biosimilars
Strong Government Support and Favorable Reimbursement Policies
Propel Market Growth
Challenges
Development of Autoinjectors for Multiple Drug Viscosities:
A Major Challenge
Increasing Demand for Alternative Drug Delivery Modes Hampers
Market Growth
Emergence of Oral Diabetic Agents, Oral Insulin and Epinephrine
Nasal Sprays Poses Huge Challenge for Autoinjectors Market
Product Overview
Autoinjector: Definition


4. GLOBAL MARKET PERSPECTIVE

Table 1: Autoinjectors Global Market Estimates and Forecasts in
US$ Million by Region/Country: 2018-2025
Table 2: Autoinjectors Global Retrospective Market Scenario in
US$ Million by Region/Country: 2009-2017
Table 3: Autoinjectors Market Share Shift across Key
Geographies Worldwide: 2009 VS 2019 VS 2025
Table 4: Rheumatoid Arthritis (Therapy) World Market by
Region/Country in US$ Million: 2018 to 2025
Table 5: Rheumatoid Arthritis (Therapy) Historic Market
Analysis by Region/Country in US$ Million: 2009 to 2017
Table 6: Rheumatoid Arthritis (Therapy) Market Share Breakdown
of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
Table 7: Multiple Sclerosis (Therapy) Potential Growth Markets
Worldwide in US$ Million: 2018 to 2025
Table 8: Multiple Sclerosis (Therapy) Historic Market
Perspective by Region/Country in US$ Million: 2009 to 2017
Table 9: Multiple Sclerosis (Therapy) Market Sales Breakdown by
Region/Country in Percentage: 2009 VS 2019 VS 2025
Table 10: Anaphylaxis (Therapy) Geographic Market Spread
Worldwide in US$ Million: 2018 to 2025
Table 11: Anaphylaxis (Therapy) Region Wise Breakdown of Global
Historic Demand in US$ Million: 2009 to 2017
Table 12: Anaphylaxis (Therapy) Market Share Distribution in
Percentage by Region/Country: 2009 VS 2019 VS 2025
Table 13: Diabetes (Therapy) World Market Estimates and
Forecasts by Region/Country in US$ Million: 2018 to 2025
Table 14: Diabetes (Therapy) Market Historic Review by
Region/Country in US$ Million: 2009 to 2017
Table 15: Diabetes (Therapy) Market Share Breakdown by
Region/Country: 2009 VS 2019 VS 2025
Table 16: Other Therapies (Therapy) World Market by
Region/Country in US$ Million: 2018 to 2025
Table 17: Other Therapies (Therapy) Historic Market Analysis by
Region/Country in US$ Million: 2009 to 2017
Table 18: Other Therapies (Therapy) Market Share Distribution
in Percentage by Region/Country: 2009 VS 2019 VS 2025


III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Autoinjectors Market Share (in %) by Company: 2019 & 2025
Market Analytics
Table 19: United States Autoinjectors Market Estimates and
Projections in US$ Million by Therapy: 2018 to 2025
Table 20: Autoinjectors Market in the United States by Therapy:
A Historic Review in US$ Million for 2009-2017
Table 21: United States Autoinjectors Market Share Breakdown by
Therapy: 2009 VS 2019 VS 2025
CANADA
Table 22: Canadian Autoinjectors Market Estimates and Forecasts
in US$ Million by Therapy: 2018 to 2025
Table 23: Canadian Autoinjectors Historic Market Review by
Therapy in US$ Million: 2009-2017
Table 24: Autoinjectors Market in Canada: Percentage Share
Breakdown of Sales by Therapy for 2009, 2019, and 2025
JAPAN
Table 25: Japanese Market for Autoinjectors: Annual Sales
Estimates and Projections in US$ Million by Therapy for the
Period 2018-2025
Table 26: Autoinjectors Market in Japan: Historic Sales
Analysis in US$ Million by Therapy for the Period 2009-2017
Table 27: Japanese Autoinjectors Market Share Analysis by
Therapy: 2009 VS 2019 VS 2025
CHINA
Table 28: Chinese Autoinjectors Market Growth Prospects in US$
Million by Therapy for the Period 2018-2025
Table 29: Autoinjectors Historic Market Analysis in China in
US$ Million by Therapy: 2009-2017
Table 30: Chinese Autoinjectors Market by Therapy: Percentage
Breakdown of Sales for 2009, 2019, and 2025
EUROPE
Market Facts & Figures
European Autoinjectors Market: Competitor Market Share Scenario
(in %) for 2019 & 2025
Market Analytics
Table 31: European Autoinjectors Market Demand Scenario in US$
Million by Region/Country: 2018-2025
Table 32: Autoinjectors Market in Europe: A Historic Market
Perspective in US$ Million by Region/Country for the Period
2009-2017
Table 33: European Autoinjectors Market Share Shift by
Region/Country: 2009 VS 2019 VS 2025
Table 34: European Autoinjectors Market Estimates and Forecasts
in US$ Million by Therapy: 2018-2025
Table 35: Autoinjectors Market in Europe in US$ Million by
Therapy: A Historic Review for the Period 2009-2017
Table 36: European Autoinjectors Market Share Breakdown by
Therapy: 2009 VS 2019 VS 2025
FRANCE
Table 37: Autoinjectors Market in France by Therapy: Estimates
and Projections in US$ Million for the Period 2018-2025
Table 38: French Autoinjectors Historic Market Scenario in US$
Million by Therapy: 2009-2017
Table 39: French Autoinjectors Market Share Analysis by
Therapy: 2009 VS 2019 VS 2025
GERMANY
Table 40: Autoinjectors Market in Germany: Recent Past, Current
and Future Analysis in US$ Million by Therapy for the Period
2018-2025
Table 41: German Autoinjectors Historic Market Analysis in US$
Million by Therapy: 2009-2017
Table 42: German Autoinjectors Market Share Breakdown by
Therapy: 2009 VS 2019 VS 2025
ITALY
Table 43: Italian Autoinjectors Market Growth Prospects in US$
Million by Therapy for the Period 2018-2025
Table 44: Autoinjectors Historic Market Analysis in Italy in
US$ Million by Therapy: 2009-2017
Table 45: Italian Autoinjectors Market by Therapy: Percentage
Breakdown of Sales for 2009, 2019, and 2025
UNITED KINGDOM
Table 46: United Kingdom Market for Autoinjectors: Annual Sales
Estimates and Projections in US$ Million by Therapy for the
Period 2018-2025
Table 47: Autoinjectors Market in the United Kingdom: Historic
Sales Analysis in US$ Million by Therapy for the Period
2009-2017
Table 48: United Kingdom Autoinjectors Market Share Analysis by
Therapy: 2009 VS 2019 VS 2025
SPAIN
Table 49: Spanish Autoinjectors Market Estimates and Forecasts
in US$ Million by Therapy: 2018 to 2025
Table 50: Spanish Autoinjectors Historic Market Review by
Therapy in US$ Million: 2009-2017
Table 51: Autoinjectors Market in Spain: Percentage Share
Breakdown of Sales by Therapy for 2009, 2019, and 2025
RUSSIA
Table 52: Russian Autoinjectors Market Estimates and
Projections in US$ Million by Therapy: 2018 to 2025
Table 53: Autoinjectors Market in Russia by Therapy: A Historic
Review in US$ Million for 2009-2017
Table 54: Russian Autoinjectors Market Share Breakdown by
Therapy: 2009 VS 2019 VS 2025
REST OF EUROPE
Table 55: Rest of Europe Autoinjectors Market Estimates and
Forecasts in US$ Million by Therapy: 2018-2025
Table 56: Autoinjectors Market in Rest of Europe in US$ Million
by Therapy: A Historic Review for the Period 2009-2017
Table 57: Rest of Europe Autoinjectors Market Share Breakdown
by Therapy: 2009 VS 2019 VS 2025
ASIA-PACIFIC
Table 58: Asia-Pacific Autoinjectors Market Estimates and
Forecasts in US$ Million by Region/Country: 2018-2025
Table 59: Autoinjectors Market in Asia-Pacific: Historic Market
Analysis in US$ Million by Region/Country for the Period
2009-2017
Table 60: Asia-Pacific Autoinjectors Market Share Analysis by
Region/Country: 2009 VS 2019 VS 2025
Table 61: Autoinjectors Market in Asia-Pacific by Therapy:
Estimates and Projections in US$ Million for the Period
2018-2025
Table 62: Asia-Pacific Autoinjectors Historic Market Scenario
in US$ Million by Therapy: 2009-2017
Table 63: Asia-Pacific Autoinjectors Market Share Analysis by
Therapy: 2009 VS 2019 VS 2025
AUSTRALIA
Table 64: Autoinjectors Market in Australia: Recent Past,
Current and Future Analysis in US$ Million by Therapy for the
Period 2018-2025
Table 65: Australian Autoinjectors Historic Market Analysis in
US$ Million by Therapy: 2009-2017
Table 66: Australian Autoinjectors Market Share Breakdown by
Therapy: 2009 VS 2019 VS 2025
INDIA
Table 67: Indian Autoinjectors Market Estimates and Forecasts
in US$ Million by Therapy: 2018 to 2025
Table 68: Indian Autoinjectors Historic Market Review by
Therapy in US$ Million: 2009-2017
Table 69: Autoinjectors Market in India: Percentage Share
Breakdown of Sales by Therapy for 2009, 2019, and 2025
SOUTH KOREA
Table 70: Autoinjectors Market in South Korea: Recent Past,
Current and Future Analysis in US$ Million by Therapy for the
Period 2018-2025
Table 71: South Korean Autoinjectors Historic Market Analysis
in US$ Million by Therapy: 2009-2017
Table 72: Autoinjectors Market Share Distribution in South
Korea by Therapy: 2009 VS 2019 VS 2025
REST OF ASIA-PACIFIC
Table 73: Rest of Asia-Pacific Market for Autoinjectors: Annual
Sales Estimates and Projections in US$ Million by Therapy for
the Period 2018-2025
Table 74: Autoinjectors Market in Rest of Asia-Pacific:
Historic Sales Analysis in US$ Million by Therapy for the
Period 2009-2017
Table 75: Rest of Asia-Pacific Autoinjectors Market Share
Analysis by Therapy: 2009 VS 2019 VS 2025
LATIN AMERICA
Table 76: Latin American Autoinjectors Market Trends by
Region/Country in US$ Million: 2018-2025
Table 77: Autoinjectors Market in Latin America in US$ Million
by Region/Country: A Historic Perspective for the Period
2009-2017
Table 78: Latin American Autoinjectors Market Percentage
Breakdown of Sales by Region/Country: 2009, 2019, and 2025
Table 79: Latin American Autoinjectors Market Growth Prospects
in US$ Million by Therapy for the Period 2018-2025
Table 80: Autoinjectors Historic Market Analysis in Latin
America in US$ Million by Therapy: 2009-2017
Table 81: Latin American Autoinjectors Market by Therapy:
Percentage Breakdown of Sales for 2009, 2019, and 2025
ARGENTINA
Table 82: Argentinean Autoinjectors Market Estimates and
Forecasts in US$ Million by Therapy: 2018-2025
Table 83: Autoinjectors Market in Argentina in US$ Million by
Therapy: A Historic Review for the Period 2009-2017
Table 84: Argentinean Autoinjectors Market Share Breakdown by
Therapy: 2009 VS 2019 VS 2025
BRAZIL
Table 85: Autoinjectors Market in Brazil by Therapy: Estimates
and Projections in US$ Million for the Period 2018-2025
Table 86: Brazilian Autoinjectors Historic Market Scenario in
US$ Million by Therapy: 2009-2017
Table 87: Brazilian Autoinjectors Market Share Analysis by
Therapy: 2009 VS 2019 VS 2025
MEXICO
Table 88: Autoinjectors Market in Mexico: Recent Past, Current
and Future Analysis in US$ Million by Therapy for the Period
2018-2025
Table 89: Mexican Autoinjectors Historic Market Analysis in US$
Million by Therapy: 2009-2017
Table 90: Mexican Autoinjectors Market Share Breakdown by
Therapy: 2009 VS 2019 VS 2025
REST OF LATIN AMERICA
Table 91: Rest of Latin America Autoinjectors Market Estimates
and Projections in US$ Million by Therapy: 2018 to 2025
Table 92: Autoinjectors Market in Rest of Latin America by
Therapy: A Historic Review in US$ Million for 2009-2017
Table 93: Rest of Latin America Autoinjectors Market Share
Breakdown by Therapy: 2009 VS 2019 VS 2025
MIDDLE EAST
Table 94: The Middle East Autoinjectors Market Estimates and
Forecasts in US$ Million by Region/Country: 2018-2025
Table 95: Autoinjectors Market in the Middle East by
Region/Country in US$ Million: 2009-2017
Table 96: The Middle East Autoinjectors Market Share Breakdown
by Region/Country: 2009, 2019, and 2025
Table 97: The Middle East Autoinjectors Market Estimates and
Forecasts in US$ Million by Therapy: 2018 to 2025
Table 98: The Middle East Autoinjectors Historic Market by
Therapy in US$ Million: 2009-2017
Table 99: Autoinjectors Market in the Middle East: Percentage
Share Breakdown of Sales by Therapy for 2009, 2019, and 2025
IRAN
Table 100: Iranian Market for Autoinjectors: Annual Sales
Estimates and Projections in US$ Million by Therapy for the
Period 2018-2025
Table 101: Autoinjectors Market in Iran: Historic Sales
Analysis in US$ Million by Therapy for the Period 2009-2017
Table 102: Iranian Autoinjectors Market Share Analysis by
Therapy: 2009 VS 2019 VS 2025
ISRAEL
Table 103: Israeli Autoinjectors Market Estimates and Forecasts
in US$ Million by Therapy: 2018-2025
Table 104: Autoinjectors Market in Israel in US$ Million by
Therapy: A Historic Review for the Period 2009-2017
Table 105: Israeli Autoinjectors Market Share Breakdown by
Therapy: 2009 VS 2019 VS 2025
SAUDI ARABIA
Table 106: Saudi Arabian Autoinjectors Market Growth Prospects
in US$ Million by Therapy for the Period 2018-2025
Table 107: Autoinjectors Historic Market Analysis in Saudi
Arabia in US$ Million by Therapy: 2009-2017
Table 108: Saudi Arabian Autoinjectors Market by Therapy:
Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED ARAB EMIRATES
Table 109: Autoinjectors Market in the United Arab Emirates:
Recent Past, Current and Future Analysis in US$ Million by
Therapy for the Period 2018-2025
Table 110: United Arab Emirates Autoinjectors Historic Market
Analysis in US$ Million by Therapy: 2009-2017
Table 111: Autoinjectors Market Share Distribution in United
Arab Emirates by Therapy: 2009 VS 2019 VS 2025
REST OF MIDDLE EAST
Table 112: Autoinjectors Market in Rest of Middle East: Recent
Past, Current and Future Analysis in US$ Million by Therapy for
the Period 2018-2025
Table 113: Rest of Middle East Autoinjectors Historic Market
Analysis in US$ Million by Therapy: 2009-2017
Table 114: Rest of Middle East Autoinjectors Market Share
Breakdown by Therapy: 2009 VS 2019 VS 2025
AFRICA
Table 115: African Autoinjectors Market Estimates and
Projections in US$ Million by Therapy: 2018 to 2025
Table 116: Autoinjectors Market in Africa by Therapy:
A Historic Review in US$ Million for 2009-2017
Table 117: African Autoinjectors Market Share Breakdown by
Therapy: 2009 VS 2019 VS 2025


IV. COMPETITION

ABBVIE
ANTARES PHARMA, INC.
CONSORT MEDICAL PLC
ELI LILLY AND COMPANY
HASELMEIER GMBH
MYLAN NV
OWEN MUMFORD
SHL GROUP
TEVA PHARMACEUTICAL INDUSTRIES
YPSOMED AG
ALK-ABELLO AS
AMNEAL PHARMACEUTICALS
APTARGROUP, INC.
ASAHI KASEI CORPORATION
ASCENDIS PHARMA A/S
ASTRAZENECA PLC
ATS AUTOMATION TOOLING SYSTEMS INC.
BAUSCH HEALTH COMPANIES INC.
BAYER AG
BD MEDICAL - PHARMACEUTICAL SYSTEMS
BIOGEN INC.
BIOMARIN PHARMACEUTICAL
BIOPROJET PHARMA
BRISTOL-MYERS SQUIBB COMPANY
CAMBRIDGE CONSULTANTS
CELLTRION HEALTHCARE
CHUGAI PHARMACEUTICAL
CINNAGEN
CREARE
CROSSJECT SA
DONGBAO ENTERPRISE GROUP
DR. REDDY’S LABORATORIES LTD.
EISAI CO., LTD.
EMD SERONO
EMERGENT BIOSOLUTIONS
F. HOFFMANN-LA ROCHE LTD.
FERRING INTERNATIONAL CENTER SA (FERRING PHARMACEUTICALS)
GENENTECH, INC.
GERRESHEIMER AG
GILEAD SCIENCES, INC.
IPSEN GROUP
JCR PHARMACEUTICALS
JIANGSU DELFU MEDICAL DEVICE
KYOWA HAKKO KIRIN CO., LTD.
LINCOLN MEDICAL
MERCK & CO., INC.
MERCK KGAA
MYLAN PHARMACEUTICAL PVT.
NEMERA
NGM BIOPHARMACEUTICALS
NIPRO CORPORATION
NOVARTIS AG
NOVO NORDISK A/S
PALATIN TECHNOLOGIES
PFIZER, INC
PHILLIPS-MEDISIZE, A MOLEX COMPANY
PORTESCAP
REGENERON PHARMACEUTICALS, INC.
SANDOZ INTERNATIONAL GMBH
SANOFI SA
SCHOTT AG
SCHREINER GROUP GMBH & CO. KG
SHIONOGI & CO., LTD.
SUMITOMO DAINIPPON PHARMA CO., LTD.
SUN PHARMACEUTICAL INDUSTRIES LIMITED
TERUMO CORPORATION
UCB SA
US WORLDMEDS
VITRONIC DR.-ING. STEIN BILDVERARBEITUNGSSYSTEME GMBH
WEST PHARMACEUTICAL SERVICES
XERIS PHARMACEUTICALS
DAIKYO SEIKO, LTD.
ENBREL
MEDAC GMBH
MERIDIAN MEDICAL TECHNOLOGIES, INC.
NUANCE DESIGNS OF CT, LLC
ONE WORLD DESIGN & MANUFACTURING GROUP, LLC
OVAL MEDICAL TECHNOLOGIES LTD.
RAVIMED
SHL MEDICAL AG
TEAM CONSULTING
UNION MEDICO APS
ZION CLINICAL PHARMACY
AGUETTANT
AGUETTANT LABORATORY
ANDROSYSTEMS
CHANGZHOU DELFU TECHNOLOGY
CHEMPROTECT.SK S.R.O.
AKTIVAX, INC.
V. CURATED RESEARCH
Read the full report: https://www.reportlinker.com/p05797940/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

What to Read Next